DDW 2018: PPIs Are Taken Inappropriately by Patients With GERD

June 5, 2018—Washington, DC—In patients with gastroesophageal reflux disease, proton pump inhibitors are initiated at the appropriate dose as per American College of Gastroenterology guidelines.

Lifestyle modifications are seldom discussed by primary care providers, and the majority of patients continue to take proton pump inhibitors after 8 weeks.

This conclusion, based on results of a retrospective chart review, was presented at Digestive Disease Week (DDW) 2018, from June 2 – 5.

Proton pump inhibitors have been reported recently to be associated with multiple serious side effects including chronic kidney disease, dementia, infection, osteoporotic fracture, cardiovascular events, and increased mortality.

Continue reading...…..

Recommended Reading
Proton pump inhibitors (PPIs) are medicines that work by reducing the amount of stomach acid made by glands in the lining of your stomach.